CEBEXAN - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Image for trademark with serial number 79331138
Serial Number
79331138
Word Mark
CEBEXAN
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2022-01-13
Filing Date
2021-09-23
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261105, 261121 - Rectangles made of broken or dotted lines. Rectangles that are completely or partially shaded.
Statements
Indication of Colors claimed
The color(s) black, green and blue is/are claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for use in gynaecology; pharmaceutical preparations and substances for use in the field of anaesthesia; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances with analgesic properties; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances with anti-inflammatory properties; pharmaceutical preparations and substances with antipyretic properties; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin diseases; pharmaceutical preparations for treating wounds; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of worms in pets; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations against dry skin caused by pregnancy; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for activating cellular functions; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for skin moisturizing during pregnancy; pharmaceutical preparations for adapting immunity; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations to prevent stretch marks; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for treating Parkinson's disease; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating sports related injuries; pharmaceutical preparations for treating cardiac arrhythmias; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for human use; pharmaceutical preparations for treating eye diseases and conditions; pharmaceutical preparations for treating multiple sclerosis; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the prevention of bacteria-based diseases; pharmaceutical preparations to prevent allergies; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the prevention immune system related disorders; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of musculoskeletal diseases; pharmaceutical preparations for the prevention of diseases of the nervous system pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of endocrine system related disorders; pharmaceutical preparations for the prevention of immune system related diseases; pharmaceutical preparations for the treatment of metabolic system related diseases; pharmaceutical preparations for the prevention of the metabolic system related disorders; pharmaceutical preparations for the treatment of metabolic system related disorders; pharmaceutical preparations for the prevention of endocrine system related disorders; pharmaceutical preparations for the treatment of genitourinary system related disorders; pharmaceutical preparations for the prevention genitourinary system related disorders; pharmaceutical preparations for the prevention of metabolic system related diseases; pharmaceutical preparations for the treatment of endocrine system related diseases; pharmaceutical preparations for the prevention of respiratory system related disorders; pharmaceutical preparations for the prevention of musculoskeletal system related diseases; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for skin wounds; hair care pharmaceutical preparations; pharmaceutical preparations for treating esophagitis; pharmaceutical preparations for the prevention of ocular disorders; pharmaceutical preparations for the treatment of genitourinary system related diseases; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for the treatment of bacteria-based disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of bacteria-based disorders; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for use in haematology; pharmaceutical preparations for the prevention of respiratory diseases; pharmaceutical preparations for the prevention of endocrine system related diseases; pharmaceutical preparations for the prevention of eye diseases; pharmaceutical preparations for the prevention of genitourinary system related diseases; pharmaceutical preparations for ear diseases; pharmaceutical preparations for treating epilepsy; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for inhalers; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for treating metabolism disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for the treatment of digestive system related diseases; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of sensory organs diseases; pharmaceutical preparations for the treatment of radiation sickness symptoms; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for treating rheumatic diseases; pharmaceutical preparations for treating arthritis; pharmaceutical products for injection; pharmaceutical products for the prevention of autoimmune diseases; pharmaceutical products for the treatment of kidney diseases; pharmaceutical products for the prevention of diabetes; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of autoimmune diseases; pharmaceutical products for the treatment of kidney diseases; pharmaceutical products for smoking cessation; pharmaceutical products for inducing erection; pharmaceutical products for the treatment of erectile dysfunction; pharmaceutical products for animal skincare; pharmaceutical products against diabetes; pharmaceutical products against bacteria; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical products for treating depression; pharmaceutical products for ocular use; pharmaceutical compositions; pharmaceutical moisturizing body lotion
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2022-01-18
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Vesna Gorjup Zupancic, lawyer
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1639086
International Registration Date
2021-09-23
International Publication Date
2022-01-13
International Renewal Date
2031-09-23
Auto Protection Date
2023-07-13
International Status
001 - Request for extension of protection established
International Status Date
2022-01-13
Priority Claimed In
True
Priority Claimed Date
2021-04-29
First Refusal In
False
Trademark Events
Event DateEvent Description
2022-01-13SN ASSIGNED FOR SECT 66A APPL FROM IB
2022-01-18NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2022-01-22APPLICATION FILING RECEIPT MAILED